proteomics
Proteomics
PamGene, Alithea Genomics, Lausanne University get €1M for Pan-Cancer Blood Test
The Dutch-Swiss Mainline consortium plans to develop a multiomics model to guide immune checkpoint inhibitor therapy across a broad range of cancers.
The firm is working on more assays to help decide which cancer patients are suitable for immunotherapies and hopes to establish a US-based lab in 2023.
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
Bio-Techne Fiscal Q3 Revenues Rise 19 Percent
The company's Diagnostics and Genomics segment revenues were up 34 percent, while its Protein Sciences segment revenues grew 15 percent.
Fluidigm Obtains $250M Investment, Changing Name to Standard BioTools
The firm intends to simplify the design and execution of deep cell profiling, and standardize sample analysis with reproducible workflows and automation.